1533 salicylic acid (1-8-3 6 g/day) in hospital (figure). The two other patients had taken acetylsalicylic acid before admission and had raised serum AST concentrations, which were subsequently normal. Serum AST concentrations were affected in all, and gamma-glutamyltransferase and glutamic purpuric transaminase concentrations were also affected in four patients. All other liver function tests were normal. No patient was taking other drugs (including alcohol) known to influence liver function tests, and all had negative tests for hepatitis B antigen.
Comment
The characteristics of aspirin hepatotoxicity have been clearly defined from this and previous studies.5-5 It is dose-dependent (generally requiring a blood concentration of 25 mg/100 ml) and is independent of the form of salicylate given. The biochemical changes (mainly affecting serum AST and serum alanine transaminase (ALT; SGPT)) concentrations are much more striking than structural Arrow at day 0 shows when aspirin was stopped.
changes in the liver, and the abnormalities are quickly reversible on stopping the drug. The liver damage due to salicylate seems to be a direct toxic effect of the drug. There are few markers of allergy in patients, either clinically, on histological examination of the liver, or on peripheral blood examination. In one study2 an associated rise in eosinophil count was noted in all of six patients with juvenile rheumatoid arthritis. In only one was this rise pronounced. None of our patients showed a peripheral blood eosinophilia. Liver biopsy was not performed in any of the patients with salicylate-related abnormalities. The histological changes are non-specific and resolve rapidly on aspirin withdrawal. Biopsy was therefore unjustifiable on ethical grounds. Similar arguments apply to rechallenge with aspirin to confirm the diagnosis, which has been shown4 5to reproduce the predictable response without yielding further information (even when combined with biopsy). The epidemiology of aspirin hepatotoxicity is not fully known, but the seven patients in this series who developed hepatotoxicity were the only ones known to be taking regular, high-dose salicylate treatment. This suggests that a substantial proportion of patients with SLE or MCTD will develop abnormalities of liver function when exposed to salicylates. Several of the patients reported in this study have required further analgesia and we have substituted diflunisal, an aspirin derivative without the ortho-acetyl group. Four patients were treated with diflunisal 500 mg twice daily. Over a two-month followup period no patients showed a rise in serum AST or other enzymes and the drug was well tolerated. This suggests that hepatotoxicity may be associated with the ortho-acetyl moiety of aspirin, and that diflunisal might be a useful alternative anti-inflammatory agent in SLE. Sarcoid lesion in breast after probable sarcoidosis in lung Sarcoid lesions in breast tissue are rare. Scadding' described one case in which they occurred and cited five others, in one of which the diagnosis was considered doubtful.
Case report
A 22-year-old white woman was seen because of wheeze, but no cause was found. At follow-up three months later a chest radiograph showed nonspecific linear shadowing confined to the right upper lung. She had been a non-reactor to tuberculin at school but had not had BCG. At the time the x-ray shadow appeared she did not react to 10 TU but did react to 100 TU (20 mm). Laryngeal swabs were negative for acid-fast bacilli. She was given para aminosalicylic acid-isnioazid for eight months without any change in the radiological appearances. She subsequently underwent a Kveim test, which gave a negative result. Gas exchange was not impaired. Lung biopsy was not thought to be justifiable. The Bone marrow aplasia is an uncommon but serious sequel to acute infectious hepatitis. This form of aplasia occurs predominantly in teenagers and young adults, typically running a protracted course with a mortality of 85%/" during the first 16 months in 174 cases reported up to 1975.1 Early bone marrow transplantation has been advocated because of this ominous prognosis.2 We have, however, observed a case of marrow depression associated with acute infectious hepatitis which displayed features departing considerably from the reported pattern: the aplasia did not affect megakaryocytes, and complete haematological recovery occurred after four weeks of myeloid and erythroid aplasia.
A 26-year-old woman in the third trimester of her second pregnancy developed polyarthralgia, malaise, and maculopapular rash, followed after five weeks by features of acute hepatitis. The liver was moderately enlarged and there was no splenomegaly or lymphadenopathy. Sole exposure to drugs had been penicillin administered during the preceding week. Plasma concentration of bilirubin was 20 4mol/l, alkaline phosphatase 370 IU/1, and Antibody to Epstein-Barr virus was not determined. Liver function deteriorated further, and three weeks later a healthy premature infant was delivered. At this time the patient developed fever, and severe neutropenia was detected. Marrow aspiration and trephine showed considerable erythroid and complete myeloid depression but normal numbers of megakaryocytes. Severe neutropenia persisted for 27 days and was associated with high fever. Treatment consisted of intravenous antibiotics, bowel sterilisation, and 17 leucocyte transfusions. Extensive postpartum haemorrhage secondary to clotting factor deficiency was treated successfully with fresh frozen plasma. The platelet count remained normal throughout the illness except for a transient fall during the haemorrhage, and was attributed to effects of transfusion with 26 units of blood in four days. Weekly studies showed no change in the bone marrow until neutrophils reappeared in peripheral blood on day 27. The aspirate then showed 33 % erythroblasts and 62 0/ granulocyte precursors. The fever resolved, and normal blood counts were permanently restored after two days. Resolution of abnormal liver function required three months before serum alkaline phosphatase became normal. Needle biopsy of the liver on day 28 showed a picture consistent with resolving acute viral hepatitis.
Comment
Marrow depression is a well-recognised sequel to acute infectious hepatitis, but this case indicates that there may be greater variability in the marrow injury and its course than had been appreciated.' 2 No explanation for the deviation from the usual pattern of protracted aplasia affecting all cell series was evident from the features of the preceding hepatitic illness, which satisfied accepted criteria.' 2 Serological evidence indicated that the hepatitis was not due to hepatitis B, which was consistent with previous experience,' but due to non-A, non-B viral hepatitis.3 The spontaneous recovery of haemopoiesis clearly indicates that progression to protracted aplasia is not inevitable, and that in our patient early marrow transplantation would have been inappropriate. In one other case aplasia affected only myeloid series, but death from sepsis supervened,4 so that it remains to be established whether persistence of one or two cell series predisposes to earlier haemopoietic recovery.
One possible pathogenic mechanism is an autoimmune process initiated by viral infection and directed against haemopoietic tissue,5 although this case provided no supportive evidence as recovery occurred in the absence of glucocorticoid or cytotoxic immunosuppressive treatment.
We thank Dr B Dwycr for referring this patient. Hagler, L, et al, Medicine, 1975 , 54, 139. 2 Camitta, B M, et al, Blood, 1974 Lehman, N I, and Gust, I D, Medical3tournal of Australia, 1977, 2, 731. 4 Dische, F E, and Golding, J R, British Medical3Journal, 1957, 
